Events | GWG 2017 Conference | Speakers
Speakers
Joel Bader
Mistakes Were Made
Maciej Maselko
Engineering Species-Like Barriers: A New Paradigm for Genetic Biocontainment and Biocontrol
Kelsie Becklin
Validation of Osteosarcoma Oncogenes Using a Medium Throughput Screen
Emily Camilleri
Sleeping Beauty Transposon Mutagenesis Screen for Chemotherapy Resistance Mechanisms in Osteosarcoma
Nicholas Slipek
CRISPR/Cas9 Screen for TSGs in Osteosarcoma
Kyle Williams
Exploiting Novel Vulnerabilities in NF1-Associated Tumorigenesis: A Small Molecule Screen Identifies Compounds Capable of Selectively Killing NF1 Deficient Human Schwann Cells
Gabriel Martínez-Gálvez
MEDJED – A Method for Predicting Microhomology-Mediated End Joining (MMEJ) Activation and Editing Outcomes
Hind Fadel
Investigating HIV-host Factors Interaction Using Genome Engineering
Emily Pomeroy
CRISPR/Cas9 Editing of Human Primary NK Cells for Preclinical Ovarian Cancer Therapy
Szu-Yi Hsu
Re-designing Natural Product Biosynthesis in Streptomyces
Douglas Corley
Biotechnology in China
Perry Hackett
The Promises and Uncertainties of Genome Editing in Animals in the 21st Century
Aidas Nasevicius
Glo-ing the Distance in Animal Biotechnology
Keynote Speaker: David Brin
Hard choices in Human Genetic Engineering
Karl Clark
Genome Engineering Provides Clues to Medical Mysteries Shortening the Diagnostic Odyssey
Jordan Welker
pGTAG and pPRISM: Two Expanded Tool Sets for Using Short Regions of Homology for Precise DNA Integration in CRISPR Compatible Systems
Aron Geurts
Transforming a Laboratory Species Through Genome Engineering
Stephen Ekker
Modifying the Powerhouse of the Cell
Jeffery Essner
Using Short Regions of Homology for Precise DNA Integration in Zebrafish
Mark Behlke
High Fidelity Genome Editing Using RNP Complexes with a Novel Mutant HiFi Cas9
Amber St. Martin
Single Nucleotide Editing Using Chimeric APOBEC-Cas9 Complexes
Eric Hendrickson
The Mechanisms of Precise Genome Editing Using Oligonucleotide Donors
Dr. David Brown
Midwest GWG Consortia Planning
Tammy Lee Stanoch
Public Perceptions
Leili Fatehi
Re-engineering Ethics: The Need for Ethics and Governance Innovation at the Convergence of Engineering and the Life Science
Alexandra J. Greenberg
Gene Editing & the Path Forward: Thoughts From a Translational Integrator
Neil Hoffman
Regulatory Thoughts
Junqi Liu
An Improved Method for Investigating Gene Functions in Soybean Roots Using CRISPR/Cas9 and Composite Plants
Shaun Curtin
CRISPR/Cas9 Mediated Mutagenesis of Soybean, Medicago and Wheat Crops
Alaa Koleilat
Using Genome Editing to Make Zebrafish Disease Models of Hearing Loss
Sara Isakson
The Genetically Engineered Minipig as a Preclinical Model of Neurofibromatosis Type I Syndrome-Associated Nervous System Tumors
Emily Julik
Lethal Mutagenesis of HIV-1 Induced by 5-aza-2’-Deoxycytidine in Human Primary CD4+ T Cells
Alex Larsson
TraSiR: Designing a Trans-Splicing Reporter to Detect Genetic Edits in Living Cells
Hirotaka Ata
Deciphering Logics for Activating Microhomology-Mediated End Joining In-vivo
Laurence Cooper
Harnessing the Immune System From the Bench to Bedside to Boardroom
Madhusudan V. Peshwa
Autologous Gene-corrected Hematopoietic Stem Cells as Potential Treatment for X-linked Chronic Granulomatous Disease
Julianne Smith
Waging War Against Cancer Through Genome Engineering
Congressman Emmer
David Largaespada
Tracking Down Cancer Using Transposon Mutagenesis and Targeted Nucleases
Lisa Koodie
Adenovirus-Based Radioiodine Therapy and Imaging for Pancreatic Cancer
Maura McGrail
Editing the Editors: Targeting Transcriptional Regulators in RB Tumor Suppression
Alan Marmorstein
Engineering iPSC to Novel Therapeutics for Eye Diseases
Caitlin Van Lith
Ex Vivo Hepatocyte-Directed Gene Repair in a Mouse Model of Metabolic Liver Disease
Scott McIvor
Gene Transfer and Genome Engineering Strategies for Therapy of Metabolic Disease